Patient Guide: Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 41 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04862286
Status: ACTIVE_NOT_RECRUITING
Condition: Psoriasis
Phase: PHASE3

Where You Can Participate

This study is available at 41 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Fountain Valley, California
  • • Sacramento, California
  • • And 38 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977 - Join Clinical Trial NCTNCT04862286

How to Join This Clinical Trial - NCTNCT04862286

Learn how to participate in this PHASE3 trial studying an investigational therapy for Psoriasis. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Psoriasis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Psoriasis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04862286 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 41 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35233 - United States

Status: Contact for availability

Clinical Research Site

Fountain Valley, California 92708 - United States

Status: Contact for availability

Clinical Research Site

Sacramento, California 95815 - United States

Status: Contact for availability

Clinical Research Site

San Diego, California 92123 - United States

Status: Contact for availability

Clinical Research Site

Jacksonville, Florida 32256 - United States

Status: Contact for availability

Clinical Research Site

Saint Petersburg, Florida 33709-1405 - United States

Status: Contact for availability

Clinical Research Site

Tampa, Florida 33607 - United States

Status: Contact for availability

Clinical Research Site

Darien, Illinois 60561 - United States

Status: Contact for availability

Clinical Research Site

Rolling Meadows, Illinois 60008 - United States

Status: Contact for availability

Clinical Research Site

Reno, Nevada 89509 - United States

Status: Contact for availability

And 31 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Psoriasis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships